Hui Ying Kuo - 01 Jul 2025 Form 3 Insider Report for CapsoVision, Inc (CV)

Role: Director
Signature: /s/ Tai Vivatvaraphol, Attorney-in-Fact for Hui Ying Kuo
Issuer symbol: CV
Transactions as of: 01 Jul 2025
Net transactions value: $0
Form type: 3
Filing time: 01 Jul 2025, 21:26:33 UTC
Next filing: 07 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kuo Hui Ying	Director	C/O CAPSOVISION, INC., 18805 COX AVENUE, SUITE 250, SARATOGA	/s/ Tai Vivatvaraphol, Attorney-in-Fact for Hui Ying Kuo	01 Jul 2025	0002074262

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CV	Series H Preferred Stock							01 Jul 2025	Common Stock	34,482		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series H preferred stock is convertible on a one-to-one basis into the underlying shares of common stock at the holder's election and has no expiration date. The Series H preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering. The number of underlying shares of common stock reported in Column 3 does not reflect a one-for-3.33 reverse stock split, to be effective immediately prior to the closing to the Issuer's initial public offering.

Content

Each share of Series H preferred stock is convertible on a one-to-one basis into the underlying shares of common stock at the holder's election and has no expiration date. The Series H preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering. The number of underlying shares of common stock reported in Column 3 does not reflect a one-for-3.33 reverse stock split, to be effective immediately prior to the closing to the Issuer's initial public offering.

Remarks:

Exhibit 24 - Power of Attorney